Williams Jones & Associates’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | $594K | Sell |
6,501
-1,459
| -18% | -$133K | 0.01% | 250 |
|
2019
Q1 | $686K | Sell |
7,960
-274
| -3% | -$23.6K | 0.02% | 236 |
|
2018
Q4 | $633K | Buy |
8,234
+320
| +4% | +$24.6K | 0.02% | 230 |
|
2018
Q3 | $611K | Buy |
7,914
+69
| +0.9% | +$5.33K | 0.01% | 263 |
|
2018
Q2 | $531K | Buy |
7,845
+558
| +8% | +$37.8K | 0.01% | 283 |
|
2018
Q1 | $528K | Sell |
7,287
-187
| -3% | -$13.6K | 0.01% | 282 |
|
2017
Q4 | $562K | Buy |
7,474
+187
| +3% | +$14.1K | 0.01% | 286 |
|
2017
Q3 | $561K | Buy |
7,287
+111
| +2% | +$8.55K | 0.01% | 276 |
|
2017
Q2 | $537K | Hold |
7,176
| – | – | 0.01% | 273 |
|
2017
Q1 | $478K | Buy |
7,176
+558
| +8% | +$37.2K | 0.01% | 278 |
|
2016
Q4 | $432K | Sell |
6,618
-1,875
| -22% | -$122K | 0.01% | 287 |
|
2016
Q3 | $601K | Hold |
8,493
| – | – | 0.02% | 253 |
|
2016
Q2 | $628K | Buy |
8,493
+1,875
| +28% | +$139K | 0.02% | 235 |
|
2016
Q1 | $430K | Sell |
6,618
-1,267
| -16% | -$82.3K | 0.02% | 222 |
|
2015
Q4 | $608K | Sell |
7,885
-111
| -1% | -$8.56K | 0.03% | 209 |
|
2015
Q3 | $659K | Hold |
7,996
| – | – | 0.03% | 213 |
|
2015
Q2 | $705K | Sell |
7,996
-112
| -1% | -$9.88K | 0.03% | 223 |
|
2015
Q1 | $716K | Hold |
8,108
| – | – | 0.03% | 232 |
|
2014
Q4 | $673K | Buy |
8,108
+2,902
| +56% | +$241K | 0.03% | 233 |
|
2014
Q3 | $439K | Sell |
5,206
-999
| -16% | -$84.2K | 0.02% | 226 |
|
2014
Q2 | $503K | Sell |
6,205
-14,910
| -71% | -$1.21M | 0.02% | 214 |
|
2014
Q1 | $1.61M | Buy |
21,115
+14,910
| +240% | +$1.14M | 0.03% | 204 |
|
2013
Q4 | $447K | Buy |
6,205
+592
| +11% | +$42.6K | 0.02% | 196 |
|
2013
Q3 | $386K | Sell |
5,613
-5,246
| -48% | -$361K | 0.02% | 208 |
|
2013
Q2 | $688K | Buy |
+10,859
| New | +$688K | 0.03% | 194 |
|